EAAT3 Polyclonal Antibody

SLC1A1 encodes a member of the high-affinity glutamate transporters that play an essential role in transporting glutamate across plasma membranes. In brain, these transporters are crucial in terminating the postsynaptic action of the neurotransmitter glutamate, and in maintaining extracellular glutamate concentrations below neurotoxic levels. This transporter also transports aspartate, and mutations in SLC1A1 are thought to cause dicarboxylicamino aciduria, also known as glutamate-aspartate transport defect.

The EAAT3 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of the excitatory amino acid transporter 3 (EAAT3) protein. This antibody is produced using high-quality polyclonal antibodies that have been extensively validated for their specificity and sensitivity. The EAAT3 Polyclonal Antibody is suitable for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The EAAT3 protein is a member of the EAAT family of transporters, which are responsible for the uptake of glutamate, the primary excitatory neurotransmitter in the central nervous system. EAAT3 is primarily expressed in neurons and is involved in the regulation of glutamate levels in the synaptic cleft. Dysregulation of EAAT3 has been implicated in a number of neurological disorders, including epilepsy, schizophrenia, and Parkinson's disease.

The EAAT3 Polyclonal Antibody is a valuable tool for researchers studying the role of EAAT3 in these and other neurological disorders. Its high specificity and sensitivity ensure accurate and reliable results, while its versatility makes it suitable for use in a variety of experimental settings.

In summary, the EAAT3 Polyclonal Antibody is a high-quality antibody that is ideal for the detection of EAAT3 protein in a variety of applications. Its specificity, sensitivity, and versatility make it an essential tool for researchers studying the role of EAAT3 in neurological disorders.